Drugs / Dimethindene
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01026961 | Sep → Nov 2010 | — | Novartis | Withdrawn | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01448057 | Jul 2013 → Aug 2015 | Achoo syndrome, nasal cavity disorder, respiratory tract infectious disorder | Novartis | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07341776 Comparator | Jan → Dec 2026 expected | anaphylaxis, food allergy | Johannes Trueck | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dimethindene | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01026961 ↗ |
| Known as | Dimetindene maleate | “Dimetindene maleate” NCT07341776 ↗ |